Scalper1 News
Seeking to avoid being a takeover itself, Mylan (MYL) raised its offer for Perrigo (PRGO), which promptly rejected the bid, saying the proposal was worse than before. Generic drugmaker Mylan bid $60 cash and 2.2 Mylan shares for each share of Perrigo. That was worth 227.33 at Friday’s close, higher than its informal offer of $205 in unspecified cash and stock. Perrigo took little time in reject the bid saying in reality it was “lower than the Scalper1 News
Scalper1 News